Alzheimer's Disease / / edited by Thomas M. Wisniewski.

Alzheimer's disease (AD) is the most common cause of dementia. No effective pharmaceutical agents exist to halt or slow down the disease progression. There is a tremendous imperative to gain a better understanding of the pathogenesis of AD and to develop effective treatments. This book brings t...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:Australia : : Exon Publications,, 2019.
Year of Publication:2019
Language:English
Physical Description:1 online resource (1 PDF file (xvii, 255 pages)) :; illustrations
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02695nam a2200301 i 4500
001 993562314304498
005 20231108170658.0
006 m o d
007 cr#|||||||||||
008 230224s2019 at a o 000 0 eng d
035 |a (CKB)4920000001372360 
035 |a (NjHacI)994920000001372360 
035 |a (EXLCZ)994920000001372360 
040 |a NjHacI  |b eng  |e rda  |c NjHacl 
050 4 |a RC523  |b .A494 2019 
082 0 4 |a 616.831  |2 23 
245 0 0 |a Alzheimer's Disease /  |c edited by Thomas M. Wisniewski. 
264 1 |a Australia :  |b Exon Publications,  |c 2019. 
300 |a 1 online resource (1 PDF file (xvii, 255 pages)) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 |a Description based on publisher supplied metadata and other sources. 
506 |a Open access  |f Unrestricted online access  |2 star 
520 |a Alzheimer's disease (AD) is the most common cause of dementia. No effective pharmaceutical agents exist to halt or slow down the disease progression. There is a tremendous imperative to gain a better understanding of the pathogenesis of AD and to develop effective treatments. This book brings together an international team of experts to provide a comprehensive and up-to-date overview of AD. The most current information on several critical aspects of AD are presented, providing the readers with a broad picture of the underlying neuropathology, genetics, proteomics, risk factors, novel biomarkers, and potential interventions. Chapters 1-5 discuss the underlying AD pathogenesis using genomic and proteomic approaches, linking diverse pathways that can lead to complex metabolic dysfunction. Chapter 6 reviews the potential role of trace metals in AD, while Chapter 7 examines the diversity of Aβ species involved in AD pathology. Chapter 8 discusses the contributions of white matter degeneration in AD. Chapter 9 examines the potential intriguing role of the brain-gut-microbiota axis in mediating AD. Chapters 10 and 11 discuss potential biomarkers for AD, such as deficits in ocular exploration and early language impairments, respectively. Chapters 12-15 examine possible novel preventative and/or therapeutic methodologies such as exercise, optimizing depression therapy, and diverse psychosocial interventions. The book will be of value to clinicians and health professionals caring for patients with AD, and will provide a comprehensive and thought-provoking introduction to young investigators interested in translational aspects of the AD and related dementias. 
650 0 |a Alzheimer's disease. 
776 |z 0-646-80968-7 
700 1 |a Wisniewski, Thomas M.,  |e editor. 
906 |a BOOK 
ADM |b 2023-11-09 11:42:46 Europe/Vienna  |f system  |c marc21  |a 2022-09-22 08:09:39 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338263590004498&Force_direct=true  |Z 5338263590004498  |b Available  |8 5338263590004498